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The living cell depends on its enzymes1 to carry 
out the chemical reactions necessary for its sur­
vival. Enzymes are catalysts; they increase the 
speed of chemical reactions without altering the 
nature or result of the reaction. As an example, 
consider lactase, the trivial name for an enzyme 
which is found in the lining of the intestine. (Its 
official name and number are /J-D-galactoside 
galactohydrolase, E.C. 3.2.1.23.2) It splits milk 
sugar (lactose) into two smaller sugars (glucose 
and galactose). This change occurs spon­
taneously, but only at an extremely slow rate. 
The enzyme is essential to allow this chemical 
reaction to occur sufficiently quickly for the sugar 
to be absorbed from the intestine. Enzymes, such 
as lactase, must first combine with the chemical 
(e.g., lactose) that enters the reaction. This 
chemical is known as the substrate for the
enzyme; whilst it is attached to the enzyme, its 
shape may be altered or a second substrate may 
be fixed on to it or, as for lactose, it may be 
broken into two parts. When this change has 
occurred, the new chemical substances that have 
been formed from the substrate are released 
back into the cell. These new chemicals, e.g., 
glucose and galactose, are called the products 
of the enzyme reaction. The same enzyme can 
be used repeatedly, but unlike many other cata­
lysts, each enzyme has a limited life and must 
be replaced continuously if the cell is to survive.
Enzymes are proteins; they are made from 
polypeptides which are chains of amino-acids. 
Although only 23 amino-acids commonly occur 
in living tissue, the possible variations in their 
arrangement in polypeptides are almost infinite; 
there is virtually no end to the number of pro­
teins that can be formed from the same 23 units. 
The amino-acids that are used to make the 
polypeptides and proteins ultimately come from 
the proteins in the food which are split into 
their constituent amino-acids before absorption 
from the intestine. These amino-acids are re­
combined to make polypeptides in the ribosomes, 
the small solid particles suspended in the liquid 
cytoplasm of the cell.
Polypeptide formation in the ribosomes is con­
trolled by the nulcleic acids.3’ 4’5’6 Each nucleic 
acid has' a skeleton formed from alternate sugar 
and phosphoric acid molecules; attached to this 
skeleton are four kinds of base. A group of three 
adjacent bases (i.e., side by side on the skeleton) 
forms a code representing one of the amino-acids. 
There are three main kinds of nucleic acid: in­
formation, messenger and transfer acids. The 
information acids are confined to the nucleus of 
the cell; they represent the information that the 
cell inherits for its development and characteris­
tics. The special chemical peculiarity of the 
nucleic acids that makes them so valuable as 
information carriers is their ability to make 
copies of themselves. To be exact, a perfect copy 
is not formed; instead, a strand of nucleic acid 
is produced in which each base in the original 
acid is replaced by another base in the’ new acid. 
The information is not distorted since one par­
ticular base (e.g., C) on the original acid is 
always copied in the new acid by the same base 
(e.g., G ). These pairs of bases (e.g., C and G) 
are said to be complementary. Consequently, the 
arrangement of the bases along the skeleton of 
the new acid is strictly determined by the order 
of the bases in the original acid. When the new 
strand of acid copies itself, each base (C) will 
introduce the original base (G) into the next 
generation of nucleic acid. Clearly the third acid
ENZYME
Fig. 1—A short section from a double strand of information acid showing the skeleton of alternate sugars (S) 
and phosphates (P ) with the attached bases (C and G ). Note how the complementary bases fit together. 
The sequence C G C is the code for the amino acid arginine.
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will be identical to the original acid and all its 
information will have been accurately copied and 
preserved.
The chemical explanation for this pairing of 
the complementary bases depends on their shape. 
The new strand of acid, as it develops, is wound 
in a spiral around the original acid and it is only 
possible for the two acids to fit together when 
the pairs of complementary bases face one 
another (Fig. 1). All the nucleic acids in the 
body are copies of the nucleic acids that were 
obtained from the parents, half coming from the 
father and half from the mother. Each time a 
cell divides, the information acids are copied so 
that all the original inherited information can 
reach every cell in the body. Apart from copy­
ing the information acid to transfer inherited 
information to new cells, the order of the bases 
on the information acid can also be copied on 
to the second type of nucleic acid called the 
messenger acid.7-8 A number of compounds 
called nucleotides are joined together to make 
a messenger acid. Each nucleotide consists of 
one base joined to a sugar and a phosphoric acid 
molecule. The nucleotides are attached to one 
another through the action of an enzyme called 
a polymerase, which appears to travel along the 
length of the information acid; as it comes to 
each base on the information acid, it adds the 
complementary base, with its nucleotide, to the 
growing messenger acid. When the messenger is 
complete it passes from the nucleus to the cyto­
plasm of the cell and enters the ribosomes.9-10
At this stage the third kind of nucleic acid, 
the transfer acid, becomes important.11 One part 
of each transfer acid carries a group of three 
bases which form a code12-13 for one of the 
amino-acids. The transfer acid picks up its 
amino-acid in the cytoplasm of the cell and 
carries it into the ribosome. Each messenger acid 
passes through a series of ribosomes14 which are 
strung along its length to form a polysome, 
rather like a necklace of beads on a thread. As 
each group of three bases on the messenger acid 
enters a ribosome, it becomes attached to the 
complementary three bases on a transfer acid. 
The amino-acid that is carried by the transfer 
acid is joined to the previous amino-acid that 
corresponds to the previous three bases on the 
messenger acid. In this way a chain of amino- 
acids is produced in which the order of the 
amino-acids corresponds to the order of the 
bases on the messenger acid, and ultimately on 
the order of the bases on the information acid 
in the nucleus of the cell. A single messenger 
acid can, at the same time, direct the synthesis 
of . a number of strands of one particular poly­
peptide; each ribosome that is strung along the 
messenger acid produces its own chain of amino- 
acids. The messenger acids are rapidly destroyed7 
and polypeptide formation must stop unless more 
messengers are released from the nucleus. This 
is undoubtedly the reason for the limited life of 
an erythrocyte; it has lost its nucleus and, with it, 
the power of polypeptide formation.
A fourth type of nucleic acid has recently been 
described;15 it is the informational acid, a copy 
of the information acid which passes from the 
nucleus to the cytoplasm, where it produces mes­
senger acids that enter the ribosomes. It forms 
yet another stage in the carriage of information 
from the nucleus to control polypeptide forma­
tion in the ribosomes.
When the polypeptide chain is complete it is 
released by the ribosome. The end of the chain 
is marked by a particular group of three bases 
on the messenger acid that form a “full 
stop.” 16-17-18 Beyond the full stop, synthesis 
starts again to produce another kind of polypep­
tide. When the polypeptides become separated 
from the ribosome they coil around one another 
to make a protein. It is only possible for the 
amino-acids on the various polypeptide chains 
to fit together and form a protein when they 
have the correct shape.19 Consequently each pro­
tein has a characteristic shape which, in the final 
analysis, is determined by the order of the bases 
on the parent information acid.
An important characteristic of most enzymes 
is their specificity: they can react only with a 
very limited range of substrates that have the 
correct shape to fit inside the enzyme molecule 
(Fig. 2). Lactase, for example, can only com­
bine with a /3-D-galactoside; a quite minor 
change in the shape of the sugar, such as the 
position of any of the hydrogen and hydroxyl 
radicles attached to the carbon atoms, prevents 
its reaction with the enzyme. These transposi­
tions produce an a-D or a /3-L-galactoside or a 
/3-D-glucoside; each one of them would require 
its own specific enzyme. When a suitable /3-D- 
galactoside fits into the lactase molecule, a ten­
sion or distortion develops in the link between 
the sugars; like the medieval instrument of tor­
ture, the rack, the enzyme stretches the bond until 
it breaks.20-21
The portion of an information acid carrying 
the thousand or so bases that control the pro­
duction of one type of polypeptide is called a 
gene; it is the smallest functional unit of genetic 
material. Since each protein is made from a 
number of polypeptides, a series of genes, rather 
than a single gene, is required to direct its for-
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Fig. 2—The shape of the enzyme lysozyme, showing the fissure that receives the substrate. The substrate must 
be the correct shape to combine with the enzyme and undergo the catalytic reaction.si
mation.22 These genes are placed in order along 
the information acid in the nucleus, with the 
code for a full-stop between each of them. When 
a messenger acid is produced it carries the in­
formation to the ribosome to make the complete 
collection of polypeptides for the whole protein.
Quite commonly a group of proteins are pro­
duced in a cell simultaneously. This is particu­
larly true for the enzymes, for example, when 
a bacterium makes the enzyme lactase two other 
enzymes, that are needed to allow lactose to enter 
the bacterial cell, are synthetised by the ribo­
somes.7 The genes controlling the formation of 
this group of enzymes are all found along the 
same length of information acid; they can all
be copied on to the same messenger acid so that 
it can produce the complete set of enzymes as it 
passes through the ribosome.7
The formation of an enzyme in a cell is con­
trolled by the information acids in its nucleus; 
this acid is a copy of the information acid ob­
tained from the parents and is identical in every 
cell in the body. This implies that all the cells 
in the body contain the essential information for 
making every kind of enzyme. It is quite clear 
that, in fact, this does not occur; the same 
enzymes are not found in every cell of the body; 
many enzymes are restricted, often to only one 
type of cell. A good example is lactase; it is an 
enzyme that is only found in the cells lining the
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small intestine. The explanation must be that 
although the nuclei of the other cells in the body 
contain the appropriate base code or genes for 
making lactase, this particular part of their in­
formation acid is not working.
It has been suggested by Monod and lacob7-23 
from their work on bacteria that there are 
special kinds of gene on the information acid 
that control and regulate the other genes. In 
addition to the structural genes that contain in­
formation for making enzymes and other pro­
teins, three more types of genetic information 
can be found on the information acid. Like the * 
structural genes, these genes form a code depend­
ing on the order of the bases along the informa­
tion acid; this code controls the amount of
information acid carrying about 400 bases. The 
third kind of controlling gene is the promoter;26 
like the operator, it contains about 400 bases; 
it is the site on the information acid where the 
enzyme polymerase becomes attached before it 
passes over and along the structural genes to 
copy the arrangement of their bases on to a 
messenger acid. When the repressor is attached 
to the operator gene, polymerase cannot com­
bine with the promoter and information from 
the structural genes can no longer be carried to 
the ribosomes. In this way a single repressor can 
control a whole group of structural genes, each 
one of which directs the synthesis of a particular 
type of polypeptide chain. This group of genes 
can only become active again if the repressor
Fig. 3—PrOS represents a double strand of information acid showing the promoter (Pr) gene where the polymerase 
(P) becomes attached, followed by the operator (O) gene and the structural (S) genes. A polymerase 
(P ') is shown copying the structural genes on to a messenger (M ) acid. The repressor (R ) can com­
bine with the operator gene so as to block the passage of the polymerase. The repressor in itself may 
be the wrong shape (apo-repressor) and require a co-repressor for its blocking action. The co-repressor 
is commonly the product of an enzyme reaction that exerts a negative feedback on the synthesis of its 
enzyme. The repressor itself may be inactivated by an inducer which is commonly the substrate (e.g., 
lactose) of the enzyme (lactase) that it induces.
messenger acid that can be copied from the 
structural genes. The first of the controlling 
genes is called the regulator gene; it can be copied 
on to a kind of messenger acid which behaves 
as a repressor and prevents information from the 
structural genes reaching the ribosomes to control 
protein synthesis. It may well be that the re­
pressor is not, in fact, a nucleic acid, but a small 
protein,24 probably a histone,25 that is made in 
the ribosomes according to the instructions coded 
in the repressor gene. The repressor does not 
directly affect the structural genes, but combines 
with a second type of controlling gene, the 
operator gene,7 which is a short portion of the
can be separated from the information acid. 
According to Monod and Iacob,7>27 a further 
chemical substance called the inducer has this 
effect. It combines with the repressor so that the 
bases on the information acid can be copied on 
to the messenger acid and restart polypeptide and 
protein formation. The piece of information acid 
that controls the formation of lactase and its 
two associated enzymes, together with their 
operator and promoter genes, has very recently 
been isolated from a bacterial cell28 (Fig. 3).
During the development of the embryo the 
cells become specialised to produce the various 
adult organs and tissues. This specialisation is
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undoubtedly due to part of the genetic informa­
tion in any one cell being repressed,29' 30' 31-32 so 
that only a small proportion of its information 
acids are controlling its structural development 
and chemical reactions. Certain parts of the 
embryo called organisers make nucleic acids,33 
histones34- 35 or small proteins called evocators36 
which control the development of the neighbour­
ing cells. One of the best known organisers is 
the eyeball; as it grows out as an extension of 
the brain, it releases chemicals which stimulate 
the overlying skin cells to form the cornea and 
lens of the eye. In all probability the whole 
development of the embryo is controlled in this 
way; each cell, as it is formed by the division 
of the preceding cell, comes under the influence 
of the already existing organisers;37 only a part 
of its information acid can be used to control its 
development. In its turn each new cell produces 
its own chemical evocators to control and in­
fluence the next generation of cells as they appear.
These changes that occur in the developing 
embryo can best be explained through the action 
of repressors and inducers.38' 56 The first cells to be 
formed in the developing embryo have most of 
their genes inactivated by repressors. As more 
cells are produced they will be influenced by 
the repressors and inducers released by the older 
cells; although they all contain the same genetic 
material, some of their repressed genes will be 
freed by inducers and some of the previously 
active genes will be blocked by repressors. 
Evocators are probably nothing more than in­
ducers or repressors. An embryo does not grow 
at the same rate in all directions, consequently 
the rapidly growing areas, where there is a more 
rapid production of new cells, will be more in­
fluenced by the repressors and inducers from the 
more slowly growing parts of the embryo con­
taining earlier generations of cells. In this way 
the different parts of the embryo can become 
specialised and develop into different types of 
tissue. Such a mechanism requires a large surplus 
of genes, since many of them will operate for 
only a short period of embryonic development 
and comparatively few will remain effective in 
the adult.39' 40 This certainly seems to be the 
case in man: there are one thousand million base 
pairs in each Adult’s nucleus,14 but only one-tenth 
of them appear to be controlling the activities of 
the adult cell.
The action of these inducing chemicals ex­
plains why the ability to produce the enzyme 
lactase is restricted to the cells lining the small 
intestine. In all the other cells in the body the 
information acid that controls lactase formation 
has been inactivated or repressed. Although a
cell in a fully developed individual may have 
retained its capacity to make a particular enzyme 
throughout the whole of its development, it does 
not necessarily follow that it will, in fact, pro­
duce the enzyme, except in minute quantities. 
The amount of an enzyme made in a cell is also 
determined by the availability of its substrate; 
the substrate is necessary to act as an inducer;27' 42 
it combines with the repressor to free the gene 
for the enzyme’s formation. Lactase is an excel­
lent example: although it is almost always present 
in a young child’s intestine, it often disappears 
in the adult. I first became aware of this problem 
when working in Persia. The American Red 
Cross sent a large quantity of dried milk powder 
to parts of the country where the protein in the 
diet was inadequate. I was very surprised to find 
that the Persian people refused to use the milk 
powder and complained that it was poisoned and 
caused diarrhoea. The milk powder was used in 
the children’s hospital without ill effects and it 
seemed to me, at the time, that an intolerance 
to milk was unlikely since milk was a common 
part of the Persian diet. I now realise that the 
explanation is the disappearance of lactase in 
the adult Persian, possibly because there is no 
lactose in the diet. The universal practice in 
Persia is to turn all their milk into a form of 
yoghourt called mosst, a process that converts 
the lactose to lactic acid. Virtually all Euro-, 
pean and North American adults have fresh 
milk containing lactose in their diet; the lactose 
is an inducer for lactase and prevents the re­
pression of its genes in the intestinal cells. 
Adults in many other parts of the world, parti­
cularly the tropics, e.g., Uganda,43 are unable to 
use fresh milk and their lactase becomes re­
pressed. A recent study by Clain44 shows that 
lactase is deficient in all adults of Mashona 
origin, although symptoms of intolerance very 
rarely occur. The disappearance of lactase in the 
adult does not only depend on the absence of 
lactose from the diet; it is also an inherited 
characteristic. There are two distinct sets of 
genes controlling lactose formation; they produce 
two separate but closely related enzymes. Such 
pairs of enzymes with the same action, but a 
slightly different structure, are called isoenzymes. 
It has been found that the isoenzyme, lactase 2, 
is always present in the adult and that a defi­
ciency is confined to the lactase 1 isoenzyme.45
Even though a cell contains an enzyme, the 
enzyme may not exist in its active form; it may 
be inhibited and unable to enter into the catalytic 
reactions, presumably because it is unable to 
combine with its substrate. Again, the best ideas 
in this field come from Monod and Jacob;46 they
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suggest that enzyme molecules can exist in two 
shapes:47 one is active and the other inhibited. 
Activation can be brought about by small mole­
cules and ions, particularly Ca++ and Mg++, 
which convert the enzyme to its active form,48 
Other compounds known as inhibitors react with 
the enzyme and alter its shape so that it cannot 
combine with its substrate.49 Inhibition is com­
monly brought about by the products of the 
enzyme reaction, or even by the products of 
later stages in a metabolic pathway. This type 
of inhibition provides a “negative feedback” to 
prevent an excessive accumulation of the pro­
ducts of enzymatic activity, an accumulation 
which outstrips the cell’s requirements and the 
capacity of the subsequent enzyme systems.
The first example of this type of negative 
feedback was found in the erythrocyte;50 glucose 
is converted to its phosphate by an enzyme called 
hexokinase and the glucose phosphate is even­
tually split into two molecules of DPG (2, 3, 
diphosphoglycerate). DPG inhibits hexokinase 
so that a constant level of DPG is maintained 
within the erythrocyte; should the level tend to 
fall, the hexokinase becomes active and more 
glucose can be phosphorylated and split to restore 
the DPG concentration. When this feedback 
system for stabilising DPG was discovered it had 
no apparent purpose or significance; it is now 
known that DPG is of prime importance in re­
gulating the transport of oxygen by the blood. 
DPG combines with the respiratory pigment in 
the erythrocyte and changes the shape of the 
molecule so that it releases oxygen which can 
pass from the blood to the tissue cells.51 The 
greater the amount of DPG in the erythrocyte, 
the more oxygen that can be released.
Unlike the other glucose metabolites, such as 
lactic and carbonic acids, which also regulate 
oxygen transport, DPG displaces oxygen from 
haemoglobin only when the amount of oxygen 
in the blood is low; it has no effect on the 
oxygenation of haemoglobin when there is a 
plentiful supply as in the capillaries of the lungs.
A common misconception in respiratory physio­
logy is to believe that the four oxygen molecules 
attached to each haemoglobin molecule are de­
tached one by one, so that at half saturation, 
when the blood has released half of its oxygen 
content, each haemoglobin will have lost two 
oxygens arid two will remain combined with each 
, haemoglobin molecule. In fact, once the first 
oxygen has been detached, the change in the 
shape of the haemoglobin molecule52 causes the 
; other three to separate very quickly. It would 
be nearer the truth to say that at half saturation, 
half the haemoglobin is completely deoxygenated
(N.B.: not reduced) and half the molecules 
retain their full complement of four oxygens. 
Since the combination of DPG with haemo­
globin does not alter its saturation with oxygen 
in the lungs,51 it cannot affect its affinity or 
binding power for the fourth oxygen molecule; 
it causes a more rapid dissociation of the remain­
ing three as soon as the fourth has been detached.
Although the concentration of DPG in a given 
cell is stabilised by the hexokinase negative feed­
back, it is possible for the stabilised level to be 
altered to a new stable level. This re-adjustment 
occurs whenever the supply of oxygen to the 
body becomes inadequate; under these circum­
stances more of the haemoglobin is converted to 
its deoxygenated form which has a greater affinity 
for DPG. The concentration of free (i.e., un­
bound) DPG in the erythrocyte is increased, 
hexokinase is no longer inhibited and more DPG 
is produced. Even a brief period of oxygen 
deficiency can increase the amount of DPG in the 
erythrocyte and the quantity attached to haemo­
globin; more oxygen can be released in the tissue 
capillaries and counteract the oxygen deficiency. 
As Dr. Peter Jacob pointed out in a recent 
faculty lecture, these changes occur during cir­
culatory or respiratory failure, in anaemia and 
at high altitude.
A similar physiological compensation, which 
also depends on DPG, occurs when erythropoiesis 
is stimulated by the renal hormone, erythro­
poietin, during these same conditions of oxygen 
shortage. New, rather immature erythrocytes 
enter the general circulation; they have an ab­
normally high DPG content and are therefore 
more efficient in carrying oxygen to the tissues. 
As mentioned above, the erythrocytes have a 
limited life because they are unable to replace 
their enzymes. One consequence of this enzyme 
deficiency is that the older cells are unable to 
stabilise their DPG content and fail to release 
their oxygen as they pass through the tissue 
capillaries. This same defect develops in stored 
blood; although a patient’s haemoglobin concen­
tration may be raised by transfusion, this is no 
guarantee that the oxygen supply to the tissues 
has been restored.
One should enquire whether an evolutionary 
advantage accrues from DPG’s control of oxygen 
transport. Why is DPG not always present in 
high concentration to help unload oxygen at the 
tissues? May I suggest that there are two rea­
sons: first, under normal resting conditions, only 
the fourth molecule of oxygen is detached from 
oxyhaemoglobin in the capillaries; an increased 
level of DPG could not influence resting oxygen 
transport, its presence would confer no advan-
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tage and it would be wasteful to convert glucose 
to this otherwise useless metabolite. The second 
consideration is that the ability of the erythrocyte 
to increase its DPG content forms a reserve for 
use in an emergency. Under normal resting con­
ditions 70 per cent, of the oxygen in the arterial 
blood is never used; it forms a reserve to be 
used when oxygen is in short supply. In the same 
way, the increased production of D'PG during 
conditions of oxygen deprivation contributes to 
this emergency system and assists the final mole­
cules of oxygen to reach the tissue cells.
Co n c l u s io n
If there is one lesson to be learnt from the 
modern study of enzymes, it is that their mole­
cular shape is all-important. We are only just 
beginning to understand how the shape of these 
protein molecules is determined by their chemical 
structure19, 53 and how, in its turn, the shape of the 
molecule controls the enzyme’s chemical and 
catalytic activity.54-55
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